Why did this ASX biotech stock explode 36% today?

This ASX nano-cap healthcare share has leapt 47% in just a week.

| More on:
Scientist looking at a laptop thinking about the share price performance.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

ASX biotech stock PainChek Ltd (ASX: PCK) rocketed 36% higher this afternoon, prompting the ASX to issue a price query.

The Painchek share price hit a new 52-week high of 4.6 cents today. It has since slipped back to 4.3 cents at the close of trade.

The biotech stock's upward bolt today followed the same trajectory as two other micro-cap healthcare shares that charged higher this morning after releasing news updates.

ASX asks biotech to 'please explain' share price skyrocket

In its price query, the ASX referred to PainCheck's ascension from a closing price of 2.9 cents on 19 September to 4.5 cents at the time.

It also noted a "significant increase in the volume of PCK's securities traded on 20 September 2023 and today".

The ASX biotech responded by saying it knew of no reason for the stock's rapid rise.

The company confirmed it had no undisclosed news to declare.

Painchek said it was "possible that the market may be reacting to the recent issue of shares as part of the placement that was announced on 14 September 2023".

$3.55 million placement to fund product development

The ASX biotech stock has leapt 47% since announcing a successful $3.55 million capital raise among institutional, professional and sophisticated investors last Thursday.

Painchek will use the funding to continue developing its smartphone-based medical device application.

The company has an app called Painchek Universal, which allows patients who cannot self-report their level of pain to communicate this to their carers.

The app uses artificial intelligence and facial recognition to detect pain levels.

The company said it will use the placement funds for the following key purposes:

  • Continue the international commercialisation of the Adult App in aged care and for the hospital and homecare sector
  • Submit Adult App US FDA De Novo regulatory clearance application for US market entry with
  • established US partners
  • Commence commercialisation of the Infant App, including novel vocalisation technology
  • Complete a core technology upgrade and obtain ISO27001 certification

The ASX biotech company issued an investor presentation for stockholders on 14 September.

Should you invest $1,000 in Painchek Ltd. right now?

Before you buy Painchek Ltd. shares, consider this:

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now... and Painchek Ltd. wasn't one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

And right now, Scott thinks there are 5 stocks that may be better buys...

See The 5 Stocks *Returns as of 6 March 2025

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A man with a wide, eager smile on his face holds up three fingers.
Healthcare Shares

3 reasons to buy this surging ASX All Ords healthcare share today

A top expert forecasts more outperformance from this rocketing ASX healthcare stock.

Read more »

A woman reclines in a comfortable chair while she donates blood holding a pumping toy in one hand and giving the thumbs up in the other as she is attached to a medical machine to collect her blood donation.
Healthcare Shares

Down 11% in 2025, are CSL shares a good buy right now?

Are CSL shares likely to go up from here?

Read more »

Three healthcare workers look and point at at medical image
Healthcare Shares

Pro Medicus to buyback 10.4 million shares. What does this mean?

Is this a sign to buy?

Read more »

A elder man and woman lean over their balcony with a cuppa, indicating share rpice movement for ASX retirement shares
Healthcare Shares

Why I think this ASX small-cap stock is a bargain at 40 cents

Here’s why this business has a compelling outlook...

Read more »

Two doctors give the thumbs up to an x-ray
Healthcare Shares

One likely reason the market has soured on Pro Medicus

Is there opportunity for brave investors?

Read more »

Three health professionals at a hospital smile for the camera.
Healthcare Shares

Hedge the rise in your health insurance premium with these 2 ASX stocks

Sick of price rises? Get on the other side of the transaction.

Read more »

Scientists working in the laboratory and examining results.
Healthcare Shares

2 ASX 200 biotech stocks announcing big news today

Let's see how the market has responded to these announcements.

Read more »

Happy man holding Australian dollar notes, representing dividends.
Healthcare Shares

This ASX 200 stock is rocketing 17% after announcing a $300m special dividend

A huge dividend is expected to be paid to investors in the near future.

Read more »